Comments*

 
  • Life Sciences & Biomedical Research

  • Events 

    Wednesday, January 21, 2015 | 8:30 AM - 5:00 PM

    The New York Structural Biology Discussion Group 10th Winter Meeting

    Speakers: Jasna Brujic (New York University), Bridget Carragher, John Chodera, Oliver Clarke, Erik Debler, Nancy Greenbaum, David Hall, Barry Honig, Jinrang Kim (Columbia University), Nina Liu (Albert Einstein College of Medicine), Patrick Loria (Yale University), Sean McSweeney (Brookhaven National Lab), Clint Potter

    The New York Area Structural Biology Discussion Group convenes twice annually and presents talks and poster sessions from graduate students, postdocs, and laboratory heads.

    Tuesday, January 27, 2015 | 8:30 AM - 4:30 PM

    Cytokine-Based Immunotherapies

    Keynote Speaker: James W. Mier (Beth Israel Deaconess Medical Center/ Harvard Medical School, Boston, MA)
    Speakers: Stephen D. Gillies (Provenance Biopharmaceuticals, Carlisle, MA), Dario Neri (Philogen, Zurich, Switzerland), Jerome Ritz (Harvard Medical School), Gilles Uzé (Université Montpellier II, Montpellier, France), K. Dane Wittrup (Massachusetts Institute of Technology, Cambridge, MA)

    Systemic toxicity currently prevents exploiting the potential of many cytokines to treat cancer, viral infections, inflammatory and autoimmune conditions. Targeted delivery of immune-stimulatory or immune-regulatory cytokines offers much promise.

    Thursday, January 29, 2015 | 6:30 PM - 8:00 PM

    Non-Traditional Postdocs

    Speakers: Uzi de Haan (Director of Entrepreneur Postdoc Program at Cornell Tech), Karen Widbin (Director of Postdoc Program at Pfizer)

    Join the Science Alliance (NYAS) as we discuss the non-traditional postdoc’s alternatives. Topics will include differences between academia and industry, hiring and transition mechanisms, salaries and challenges.

    Monday, February 2, 2015 | 1:30 PM - 4:30 PM

    Genome Integrity Discussion Group Meeting

    Speakers: Prasad Jallepalli (Memorial Sloan-Kettering Cancer Center), Susan Smith (NYU Langone Medical Center), Iestyn Whitehouse (Memorial Sloan-Kettering Cancer Center), John Petrini (Memorial Sloan-Kettering Cancer Center)

    The Genome Integrity Discussion Group provides a forum for interactions between basic and clinical research groups working on chromosome biology and function, and at the interface between chromosome integrity and onset and progression of malignancy.

    Tuesday, February 24, 2015 | 8:30 AM - 4:30 PM

    Harnessing the Potential of Genome Editing for Drug Discovery: Translational Frontiers of in vitro and in vivo Applications

    Speakers: Chad Cowen (Massachusetts General Hospital), James Inglese (National Center for Advancing Translational Sciences, NIH), J. Keith Joung (Massachusetts General Hospital), Randall Platt (Massachusetts Institute of Technology), Yi Yang (Novartis Institutes for Biomedical Research), Lei (Stanley) Qi (University of California San Francisco)

    The emergence of genome editing technologies such as TALEN and CRISPR/Cas9 are revolutionizing our ability to rapidly engineer mammalian systems. This symposium explores the frontiers of genome editing and potential to aid therapeutic development.

  • Past Events

    Tuesday, December 9, 2014 | 8:00 AM - 5:00 PM

    Diabetic Kidney Disease: Drug Discovery and Clinical Development Challenges

    Speakers: Matthew D. Breyer (Eli Lilly and Company), Frank C. Brosius (University of Michigan Medical School), Benjamin D. Humphreys (Brigham and Women's Hospital), Matthias Meier (F. Hoffmann-La Roche Ltd), Shahnaz Shahinfar (S. Shahinfar Consulting, Inc. and The Children's Hospital of Philadelphia), Katalin Susztak (University of Pennsylvania), Aliza Thompson (Food and Drug Administration)

    Identifying and prosecuting drug targets is challenging due to a poor understanding of pathogenesis and few biomarkers. This symposium identifies targets for preventive or therapeutic interventions and discusses challenges in clinical development.

    Monday, December 1, 2014 | 1:30 PM - 4:30 PM

    Genome Integrity Discussion Group Meeting

    Speakers: Sevinc Ercan (NYU), Laura Landweber (Princeton University), Susan Smith (NYU Langone Medical Center), Renjing Wang (Memorial Sloan Kettering Cancer Center), David J. Wynne (Laboratory of Chromosome and Cell Biology, The Rockefeller University), Xiaolan Zhao (Memorial Sloan-Kettering Cancer Center)

    The Genome Integrity Discussion Group provides a forum for interactions between basic and clinical research groups working on chromosome biology and function, and at the interface between chromosome integrity and onset and progression of malignancy.

    Saturday, November 15, 2014 | 11:00 AM - 4:00 PM

    Risky Business – A Pharmaceutical Industry Strategy Workshop

    Moderator: Jan-Philipp Kruse (Catenion)

    This course gives professionals from inside and outside the pharmaceutical industry—including students and postdocs—a much better understanding of how the R&D and business development and licensing processes operate.

    Tuesday, November 11, 2014 | 5:45 PM - 7:00 PM

    Baby Talk: Closing the Achievement Gap, Word by Word

    Moderator: Michael H. Levine (Executive Director, the Joan Ganz Cooney Center at Sesame Workshop)
    Panelists: Patricia K. Kuhl (Co-Director, Institute for Learning and Behavioral Sciences (ILABS), University of Washington; Co-author, "The Scientist in the Crib: What Early Learning Tells Us About the Mind."), Patti Miller (Director, Too Small to Fail Initiative for the Clinton Foundation), Dana Suskind (Director, Pediatric Cochlear Implant Program at the University of Chicago and Founder and Director, Thirty Million Words Initiative)

    By the time they are 3, children from low-income families hear 30 million fewer words than their high-income peers. Join us for a public panel discussion on early childhood development and strategies to boost school readiness for all children.

  • Publications 

    eBriefing

    New Frontiers in the Neurobiology of Mental Illness

    Keynote Speaker: The Honorable Patrick J. Kennedy (Former U.S. Representative, Rhode Island; One Mind for Research; Kennedy Forum)

    This eBriefing explores the translation of neuroscience breakthroughs into therapies for mental illness. A keynote lecture looks at strategies to dispel stigma surrounding mental illness so that new treatments are accessible to all.

    eBriefing

    Early-life Influences on Obesity: Pre-conception to Adolescence

    Organizers: John G. Kral (SUNY Downstate Medical Center), Michael Gibney (University College Dublin), Blandine Laferrère (Columbia University), Andrew G. Swick (Metagenics), Karen Teff (National Institutes of Health), Mandana Arabi (The Sackler Institute for Nutrition Science), and Amy Beaudreault (The Sackler Institute for Nutrition Science)

    This eBriefing examines obesity risks that occur in early life and considers how to intervene to prevent and treat diabesity and related diseases.

    Annals

    Rethinking Mortality: Exploring the Boundaries between Life and Death

    Edited by Annals of the New York Academy of Sciences editorial staff

    This Annals volume presents a thought-provoking four-part series on the intersection of life and death, with a special emphasis on implications for how we understand and approach mortality from scientific, ethical, and spiritual perspectives.

    Volume 1330

    eBriefing

    Click Chemistry in Biology and Medicine

    Organizers: Peng Wu (Albert Einstein College of Medicine) and Jennifer Henry (formerly at The New York Academy of Sciences)
    Keynote Speakers: Jim Paulson (Scripps Research Institute) and K. Barry Sharpless (Scripps Research Institute)

    This eBriefing explores recent developments in the search for click reactions with applications in disease diagnosis and therapy.

  • Podcasts

    Podcast
    April 14, 2011

    The Diabetes-Gum Disease Connection

    Good oral hygiene helps prevent tooth decay and gum disease, but the health of your mouth may have a big impact on the rest of your body too—especially if you have diabetes.

    Download (11 MB, 13:03)
    Podcast
    September 10, 2010

    What Makes Us Wise?

    Can we all be wise old owls? Science journalist Stephen Hall and neuroscientist Andre Fenton dissect what we call wisdom, from the neurons in our brain, to the social constructs behind it.

    Download (22 MB, 00:42:32)
    Podcast
    August 27, 2010

    Better Brains

    Neuroscientist Richard Restak thinks with the right mental exercises, our brains can be much better. Today he teams with writer Susan Orlean to talk about our brainy potential.

    Download (35 MB, 00:54:21)
    Podcast
    August 13, 2010

    How Prosperity Evolves

    With our economy a shambles and our environment threatened, is there any reason to be optimistic about the future? Matt Ridley says there's scientific proof to say we should be.

    Download (33 MB, 00:51:28)
  • Webinar Archives

    Webinar Archive
    March 2, 2010

    Emerging Infectious Diseases in Response to Climate Change

    Climate and weather are important components of complex ecosystems, and with these changes, the dynamic balance between the living components of ecosystems is often disturbed. Experts in climate change, climate policy, emerging infectious diseases and public health discussed the relevant and pressing issues that we as a global community face as the planet's climate is altered.

    Webinar Archive
    February 23, 2010

    Metabotropic Glutamate Receptors: Translation from Discovery to Clinical Trials

    Researchers met to discuss advances in basic and translational research on metabotropic glutamate receptors, which are promising targets in drug discovery for CNS diseases and other illnesses.

    Webinar Archive
    October 27, 2009

    Is Alzheimer's Disease Type 3 Diabetes?

    What is the connection between dysregulated neuronal insulin signaling and Alzheimer's disease? In a recent Academy webinar, some researchers argued that the neurodegenerative disease should be considered a type of diabetes.

    Webinar Archive
    April 28, 2009

    Protein Kinases: Structure-Guided Drug Discovery

    Protein kinases play a key role in almost every major pathway in eukaryotic cells. Structural approaches, including a new method called fragment-based drug design, are identifying potential targets against diseases including cancer.

  • Translational Medicine Initiative

    Macy FoundationThe Translational Medicine Initiative represents a three-year partnership between the New York Academy of Sciences and the Josiah Macy, Jr. Foundation to support the translation of basic science research into clinical applications.

    Learn more at www.nyas.org/TransMed.